Duma Narjust, Croghan Ivana, Jenkins Sarah, Vachon Celine, Neal Loni, Ghosh Karthik, Pruthi Sandhya
Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin, Madison, WI.
Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Clin Pract. 2020 Oct 15;10(4):1253. doi: 10.4081/cp.2020.1253.
Vitamin D deficiency and high breast density may be associated with increased breast cancer risk. We examined a possible association between vitamin D levels and mammographic breast density in a population of Alaskan women. Patients seen in the Mayo Clinic-Alaska Native Medical Center telemedicine program from December 2014 to December 2017 were enrolled in the study. Pearson correlation was used to estimate the association between mammographic breast density and vitamin D levels. Of the 33 women enrolled, 70% of women self-identified as American Indian/Alaskan Native, 12% as White, 6% as Native Hawaiian/Pacific Islander and 12% as other. Nineteen (58%) participants were taking vitamin D supplementation. No correlation was identified between breast density and serum vitamin D levels overall (correlation= -0.03). Larger studies controlling for vitamin supplementation are needed, as this association could potentially impact breast cancer rates in populations at risk for vitamin D deficiency.
维生素D缺乏和乳腺密度高可能与乳腺癌风险增加有关。我们在阿拉斯加女性人群中研究了维生素D水平与乳腺钼靶密度之间的可能关联。2014年12月至2017年12月在梅奥诊所 - 阿拉斯加原住民医疗中心远程医疗项目中就诊的患者被纳入该研究。采用Pearson相关性分析来估计乳腺钼靶密度与维生素D水平之间的关联。在纳入的33名女性中,70%的女性自我认定为美洲印第安人/阿拉斯加原住民,12%为白人,6%为夏威夷原住民/太平洋岛民,12%为其他种族。19名(58%)参与者正在补充维生素D。总体而言,未发现乳腺密度与血清维生素D水平之间存在相关性(相关性 = -0.03)。由于这种关联可能会影响维生素D缺乏风险人群的乳腺癌发病率,因此需要进行更大规模的研究来控制维生素补充情况。